Zhu Luchang, Olsen Randall J, Musser James M
Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
mSphere. 2017 Apr 19;2(2). doi: 10.1128/mSphereDirect.00147-17. eCollection 2017 Mar-Apr.
Serum opacity factor (SOF) is a cell surface virulence factor made by the human pathogen . We found that strains with naturally occurring truncation mutations in the gene have markedly enhanced beta-hemolysis. Moreover, deletion of the gene in a SOF-positive parental strain resulted in significantly increased beta-hemolysis. Together, these observations suggest that SOF is an inhibitor of beta-hemolysis. SOF has two major functional domains, including an opacification domain and a fibronectin-binding domain. Using a SOF-positive serotype M89 parental strain and a panel of isogenic mutant derivative strains, we evaluated the relative contribution of each SOF functional domain to beta-hemolysis inhibition and bacterial virulence. We found that the opacification domain, rather than the fibronectin-binding domain, is essential for SOF-mediated beta-hemolysis inhibition. The opacification domain, but not the fibronectin-binding domain of SOF, also contributed significantly to virulence in mouse models of bacteremia and necrotizing myositis. Inasmuch as the opacification domain of SOF is known to interact avidly with host high-density lipoprotein (HDL), we speculate that SOF-HDL interaction is an important process underlying SOF-mediated beta-hemolysis inhibition and SOF-mediated virulence. is a major human pathogen causing more than 700 million infections annually. As a successful pathogen, produces many virulence factors that facilitate colonization, proliferation, dissemination, and tissue damage. Serum opacity factor (SOF), an extracellular protein, is one of the virulence factors made by . The underlying mechanism of how SOF contributes to virulence is not fully understood. SOF has two major features: (i) it opacifies host serum by interacting with high-density lipoprotein, and (ii) it inhibits beta-hemolysis on blood agar. In this study, we demonstrate that the domain of SOF essential for opacifying serum is also essential for SOF-mediated beta-hemolysis inhibition and SOF-mediated virulence. Our results shed new light on the molecular mechanisms of SOF-host interaction.
血清混浊因子(SOF)是一种由人类病原体产生的细胞表面毒力因子。我们发现,该基因发生自然截短突变的菌株具有明显增强的β溶血活性。此外,在SOF阳性亲代菌株中缺失该基因导致β溶血活性显著增加。这些观察结果共同表明,SOF是β溶血的抑制剂。SOF有两个主要功能域,包括一个混浊化域和一个纤连蛋白结合域。我们使用SOF阳性血清型M89亲代菌株和一组同基因突变衍生菌株,评估了每个SOF功能域对β溶血抑制和细菌毒力的相对贡献。我们发现,混浊化域而非纤连蛋白结合域对于SOF介导的β溶血抑制至关重要。SOF的混浊化域而非纤连蛋白结合域在菌血症和坏死性肌炎小鼠模型的毒力中也起显著作用。由于已知SOF的混浊化域与宿主高密度脂蛋白(HDL)有强烈相互作用,我们推测SOF-HDL相互作用是SOF介导的β溶血抑制和SOF介导的毒力的重要基础过程。是一种主要的人类病原体,每年导致超过7亿次感染。作为一种成功的病原体,会产生许多有助于定植、增殖、传播和组织损伤的毒力因子。血清混浊因子(SOF)是一种细胞外蛋白,是产生的毒力因子之一。SOF如何促进毒力的潜在机制尚未完全了解。SOF有两个主要特征:(i)它通过与高密度脂蛋白相互作用使宿主血清混浊,(ii)它抑制血琼脂上的β溶血。在本研究中,我们证明了SOF使血清混浊所必需的结构域对于SOF介导的β溶血抑制和SOF介导的毒力也至关重要。我们的结果为SOF-宿主相互作用的分子机制提供了新的见解。